One of the most popular DNA testing companies called 23andMe has signed a $300 million deal with a pharmaceutical giant GlaxoSmithKline, and what many feared came true. There is a grey area with who 23andMe can give the customer’s DNA to and what that second party will do with [...]
Read Full Article →
